Current Medicinal Chemistry


Atta-ur-Rahman, FRS
(32052 citations)
Kings College
University of Cambridge

Nobel Laureates on Editorial Board

Prof. John Gurdon

Prof. Jean-Marie Lehn

Prof. Ferid Murad

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Meet Our Editorial Board Member free to download

Volume:24   Issue: 11
Pp: 1049-1049
Xiaojiang Hao*
DOI: 10.2174/092986732411170531175343
Published on: 31 May, 2017

Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives

Volume:24   Issue: 11
Pp: 1050-1065
Raffaella Franca, Diego Favretto, Marilena Granzotto, Giuliana Decorti*, Marco Rabusin and Gabriele Stocco
DOI: 10.2174/0929867324666170113105733
Published on: 31 May, 2017

Trypanothione Reductase and Superoxide Dismutase as Current Drug Targets for Trypanosoma cruzi: An Overview of Compounds with Activity against Chagas Disease

Volume:24   Issue: 11
Pp: 1066-1138
Ivan Beltran-Hortelano, Silvia Perez-Silanes* and Silvia Galiano
DOI: 10.2174/0929867323666161227094049
Published on: 31 May, 2017

Visual Sexual Stimulation and Erection, a Brief Review with New fMRI Data

Volume:24   Issue: 11
Pp: 1139-1146
Sharon L. Wu, Maggie S.M. Chow, Jiang Y. L., Jingjin Yang, Hao Zhou and David T. Yew*
DOI: 10.2174/0929867323666161213102528
Published on: 31 May, 2017

Farnesoid-X Receptor (FXR) as a Promising Pharmaceutical Target in Atherosclerosis

Volume:24   Issue: 11
Pp: 1147-1157
Demetrios Moris, Constantinos Giaginis*, Gerasimos Tsourouflis and Stamatios Theocharis
DOI: 10.2174/0929867324666170124151940
Published on: 31 May, 2017

Tofacitinib, an Oral Janus Kinase Inhibitor: Perspectives in Dermatology

Volume:24   Issue: 11
Pp: 1158-1167
Kresimir Kostovic*, Sandra J. Gulin, Zrinka B. Mokos and Romana Ceovic
DOI: 10.2174/1874467210666170113104503
Published on: 31 May, 2017